Emkay Global's Dr. Satish Ugrankar steps down as Independent Director
Dr. Satish Ugrankar steps down as an Independent Director of Emkay Global Financial Services on August 9, 2026, after serving two five-year terms. He also leaves the Audit, Nomination, and Stakeholder Committees. The move is a routine governance update per SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Emkay Global Financial Services announced that Dr. Satish Ugrankar has ceased to be a member of its Board of Directors effective August 9, 2026. The departure marks the conclusion of his second consecutive five-year tenure as an Independent Director, a limit imposed by regulatory guidelines to ensure board refreshment. This change affects the composition of several key board committees, requiring the company to appoint replacements to maintain compliance with SEBI listing regulations.
The exit was disclosed pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Ugrankar’s DIN is 00043783. The Board of Directors expressed appreciation for his contributions during his tenure. In line with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, the company provided detailed disclosures regarding the change in directorship.
Committee Exits
Upon ceasing to be a director, Dr. Ugrankar automatically vacated his positions in all board committees. His roles included:
- Chairperson of the Stakeholder's Relationship Committee
- Member of the Audit Committee
- Member of the Nomination, Remuneration and Compensation Committee
These vacancies must be filled by the Board to ensure continuous oversight in these critical governance areas.
What This Means for Governance
The completion of a second term for an Independent Director is a standard procedural event under Indian corporate law, designed to prevent entrenchment and bring fresh perspectives to the board. For investors, this signals a routine governance update rather than a strategic shift or conflict. The primary implication is the administrative task of identifying and appointing a new Independent Director who meets the eligibility criteria set by SEBI. Until a successor is appointed, the remaining Independent Directors will manage the committee responsibilities, though companies typically move quickly to fill such gaps to avoid any perception of non-compliance with quorum requirements for committee meetings.
Historical Stock Returns for Emkay Global Financial Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.84% | +0.98% | -9.45% | -4.82% | +3.90% | +88.23% |
Who are the potential candidates Emkay Global Financial Services is considering to replace Dr. Ugrankar as Chairperson of the Stakeholder's Relationship Committee?
How might the departure of a long-serving Independent Director impact the company's upcoming audit processes or regulatory compliance timelines?
Are there any pending strategic decisions or shareholder resolutions that could be delayed due to the temporary vacancy in the Nomination and Remuneration Committee?


































